Assessment of beta-2 microglobulin and CD49d in patients with chronic lymphocytic leukemia pre- and posttherapy

Assessment of beta-2 microglobulin and CD49d in patients with chronic lymphocytic leukemia pre- and posttherapy

BACKGROUND: Chronic lymphocytic leukemia (CLL) is the most common type of leukemia among adults in Western countries; however, it is relatively rare in Asia. It is characterized by abnormal proliferation of lymphocytes in the blood, bone marrow, and lymphatic tissue. The measurement of serum beta-2...

Full description

Bibliographic Details
Main Authors: Abdulameer Nasser Al-Rekabi, Alaa Fadhil Alwan, Naseer Khaleel Alobaidi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Iraqi Journal of Hematology
Subjects:
beta-2 microglobulin
cd49d
chronic lymphocytic leukemia
Online Access:http://www.ijhonline.org/article.asp?issn=2072-8069;year=2020;volume=9;issue=2;spage=155;epage=159;aulast=Al-Rekabi

Internet

http://www.ijhonline.org/article.asp?issn=2072-8069;year=2020;volume=9;issue=2;spage=155;epage=159;aulast=Al-Rekabi

Similar Items